Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Enhancing Recruitment in Urinary Incontinence Care
Urinary incontinence affects over 50% of adult women yet remains underdiagnosed in primary care. A multi‑site study of five grantees examined recruitment tactics across 1,950 practices and 134,852 screened patients. Findings show that leadership buy‑in, practice‑facilitator involvement, and embedding UI screening into routine intake consistently raised recruitment, while incentives and broad outreach alone fell short. About 21% of screened patients tested positive, highlighting the unmet need.
A Sliding Scale AdaptiVe Expedited Rescue Algorithm for Deceased Donor Kidney Transplantation
Researchers introduced a Sliding Scale AdaptiVe Expedited rescue algorithm to curb the rising nonuse of deceased‑donor kidneys. The model ties a rescue trigger to real‑time nonuse rates and allocates kidneys in proportionate batches, shortening cold‑ischemic time. Simulations using KSIM 2.0 and...
Managing Urinary Incontinence
The Agency for Healthcare Research and Quality’s Managing Urinary Incontinence (MUI) Initiative examined how practice facilitators supported evidence‑based, nonsurgical UI care across five U.S. institutions and 270 primary‑care practices over two years. Interviews revealed five themes, including evolving facilitator roles,...
Innovation De-Implementation in Emergency Departments During the COVID-19 Pandemic
A qualitative study of emergency department clinicians across eight U.S. hospitals examined why COVID‑19 care innovations were discontinued. Focus groups revealed that direct observation of patient outcomes, peer discussion, supply constraints, and leadership protocols were pivotal in de‑implementation decisions. Factors...
Effect of Plain Cigarette Packaging on Point-of-Sale Purchasing Behavior Among Young Adults Who Smoke
A RAND StoreLab experiment with 433 young adult smokers tested full plain packaging, half plain packaging, and standard branding. Full‑coverage plain packs cut cigarette purchases by 46% compared with the status‑quo (adjusted OR 0.54, p = .04). Half‑coverage packs showed no impact on...
CoMira Concludes Lease Agreement for Plant in Sudair Industrial City, Saudi Arabia
Co‑Diagnostics’ joint venture CoMira Diagnostics has finalized a lease for a 14,400 ft² manufacturing plant in Saudi Arabia’s Sudair Industrial City. The turnkey facility will produce the Co‑Dx PCR platform, laboratory equipment, and medical consumables once regulatory approvals are secured. The...
Day One Concludes Patient Enrolment for Tovorafenib’s FIREFLY-2 Trial
Day One Biopharmaceuticals announced that the Phase III FIREFLY‑2 trial of tovorafenib has finished enrolling roughly 400 pediatric low‑grade glioma patients across 140 sites worldwide. The open‑label, randomized study pits oral tovorafenib against four standard chemotherapy regimens as a first‑line option...
STAT+: Medicare Is Spending Far Less than Expected on New Alzheimer’s Drugs
Medicare’s uptake of the newly approved Alzheimer’s therapies Leqembi and Kisunla is far lower than projected, prompting the agency to forecast minimal spending through 2026‑2027. Earlier estimates had anticipated billions in annual costs, but real‑world adoption has stalled. The drugs...
STAT+: Five Years After Disaster, a Rare Disease Community Gets New Chance at Treatment
Astellas Pharma has re‑initiated its gene‑therapy trial for X‑linked myotubular myopathy (XLMTM) five years after a previous study was halted by safety concerns. Early observations from the first participant, Joshua "JJ" Gonzalez, indicate a dramatic reduction in airway suctioning, suggesting...
Henlius Receives US FDA IND Clearance for HLX05-N (Biosimilar, Erbitux)
Henlius announced that the U.S. Food and Drug Administration granted Investigational New Drug (IND) clearance for HLX05‑N, its biosimilar version of Erbitux (cetuximab), aimed at treating metastatic colorectal cancer. The IND follows extensive analytical and non‑clinical studies that demonstrated high...
Across the Nutraverse: Chemist Warehouse to Enter the UK, H&B Partners with Phlo, NutraIngredients Europe Awards
Australian discount pharmacy giant Chemist Warehouse is entering the UK through a joint venture with London‑based GreenLight, converting up to five stores to its low‑margin, high‑volume format. The deal gives Sigma Healthcare a 75% stake, leveraging its recent merger with...
Nuclera Launches Antibody Triage Service to Advance AI-Driven Antibody Discovery
Nuclera, a biotech firm specializing in protein production, announced a new antibody‑screening service designed to accelerate AI‑driven antibody discovery. The offering uses a 96‑plex cell‑free expression platform and surface plasmon resonance to triage large in‑silico‑generated libraries, delivering early binding data...
Eliminating Manual Data Entry: How Automation Empowers Care Teams And Improves Outcomes
Healthcare providers are turning to AI‑driven automation to replace manual data entry and create a unified, cleansed patient record—often called a single version of the truth. By aggregating data from hospitals, labs, and patients, the system delivers real‑time, actionable summaries...
Kori Lands Latest Deal for Care UK
Kori Construction has secured its fourth partnership with Care UK, launching a new £12 million (≈$15 million) three‑storey care facility in Mitcham. Demolition of the existing building begins this week, paving the way for specialist residential, nursing and dementia accommodation. The development...
My First Thought After Having a Vasectomy: Why Aren’t More British Men Having Them? | Tim Burrows
Tim Burrows describes his own vasectomy after a two‑year NHS wait, noting the procedure is quick and low‑risk. UK vasectomy numbers have dropped 62% from 30,400 in 2004‑05 to 10,880 in 2015‑16, with men accounting for only 5.3% of contraceptive‑service...
Root Causes | Are Employers Doing Enough to Support Staff Through Britain's Dental Care Crisis?
UK workers face a mounting dental care crisis as NHS capacity dwindles. Recent British Dental Association data show 96.9% of patients without a dentist failed to secure NHS appointments, leaving many to wait months or turn to costly private care....
MDT-Based Comprehensive Management of Type 3 Von Willebrand Disease in Pregnancy: From Preimplantation Genetic Testing to Antenatal Care, Delivery and...
Researchers reported the first use of recombinant von Willebrand factor (rVWF) in China to manage a pregnancy complicated by type 3 von Willebrand disease. A 36‑year‑old patient conceived via IVF and received target‑guided rVWF dosing before amniocentesis and elective caesarean, achieving activity...
BMS’ Sotyktu (Deucravacitinib) Wins EC Approval to Treat Adults with Active Psoriatic Arthritis (PsA)
The European Commission has approved Bristol‑Myers‑Squibb’s oral drug Sotyktu (deucravacitinib) for adults with active psoriatic arthritis, either alone or with methotrexate. The decision follows positive Phase III data from the POETYK PsA‑1 and POETYK PsA‑2 trials, which enrolled over 1,200 patients and met...
Patient Perspectives on Gene Therapies and Gene Editing for Familial Cardiomyopathies
Early‑phase trials are testing gene replacement and editing for hypertrophic and dilated cardiomyopathies, yet patient viewpoints remain understudied. Interviews with 21 adults (average age 57, 57% female) revealed four decision drivers: perceived disease severity, quality‑of‑life impact, treatment safety and delivery,...
AI Tools that Cut Paperwork Could Help Tackle Rising Clinician Burnout Across the NHS
The NHS faces a massive backlog of 7.31 million planned treatments, intensifying clinician burnout as administrative duties consume personal time. Trials at Oxford University Hospitals using ambient voice technology (AVT) showed clinicians saved nearly 30 minutes per day, with 73% reporting improved...
'We Have to Respond to Women's Health Needs More Easily'
Liverpool’s health review shows women spend about 30% of their lives in poor health and die roughly ten years earlier than the national average. The report also found lung‑cancer mortality double and drug‑related deaths more than three times the England...
Assisted Dying Revived?
Supporters of assisted dying are eyeing a revival of the Terminally Ill Adults (End of Life) Bill after it lapsed during last month’s prorogation. They hope to invoke the 1911 Parliament Act to force the legislation through without House of...
Advances in RSV Vaccine Research and Development
Respiratory syncytial virus (RSV) remains a leading cause of acute lower‑respiratory infections, accounting for roughly 33 million cases and over 3 million hospitalizations each year, especially in children under five and older adults. Recent advances focus on stabilizing the prefusion F (preF)...
What Is Frozen Shoulder? And Will I Need Surgery?
Frozen shoulder, or adhesive capsulitis, affects about 8 % of men and 10 % of women aged 25‑64, with prevalence rising sharply after age 40. The condition progresses through three stages—freezing, frozen, and thawing—and can linger for months or years, often leaving residual...
Hong Kong Outlines Strategy to Strengthen Global Health Innovation and Clinical Trials
Hong Kong announced a comprehensive strategy to become a regional hub for health innovation, focusing on expanding clinical trial capacity, regulatory reform, and research commercialization. The government unveiled the Greater Bay Area International Clinical Trial Institute, a “one institute, one...
Molina Healthcare, Inc. (MOH) Analyst/Investor Day Transcript
Molina Healthcare hosted its 2026 Analyst/Investor Day on May 11, 2026, featuring presentations by CEO Joseph Zubretsky, CFO Mark Keim and COO James Edwin Woys. The event highlighted the company’s strategic focus on expanding Medicaid enrollment and improving operational efficiency. Financial leadership...
Published FDA Rejections Point to Manufacturing, Data Gaps as Key Stumbling Blocks
The FDA’s new policy to publish complete response letters (CRLs) has made over 350 rejection letters publicly available, revealing that more than half of drug rejections stem from manufacturing problems and 41% from product‑quality issues. Analysts say the transparency lets...
Overmedicalization? RFK Jr.’s Antidepressant Crackdown Raises Conflict Questions over His Fee Stake in Wisner Baum, the Tort Firm Built on...
Robert F. Kennedy Jr., now heading the U.S. Health and Human Services Agency, unveiled a "MAHA Action Plan" to curb psychiatric overprescribing, especially among children, and to promote non‑drug therapies. The initiative follows his controversial statements linking antidepressants to mass...
When Superbugs Threaten Vulnerable Children: Can AI Help Solve Antibiotic Resistance?
A wave of drug‑resistant bloodstream infections is killing newborns in Southeast Asia, highlighting the accelerating global antibiotic resistance crisis. The World Health Organization warns that the pipeline for new antibiotics is dangerously thin, leaving clinicians with few treatment options. MIT...
Report: Kentucky’s Overdose Deaths Keep Falling
Kentucky’s opioid death toll, which peaked at 2,257 in 2021, has fallen to 1,178 total deaths in 2025, including 1,100 residents, marking four consecutive years of decline. The drop follows a 30% reduction from 2023 to 2024 and a further...
This 800-Year-Old Chinese Exercise Helps Lower Blood Pressure Naturally
A large multicenter randomized trial published in JACC found that practicing baduanjin, an 800‑year‑old Chinese exercise, lowered systolic blood pressure as effectively as brisk walking. Over 216 adults with stage 1 hypertension performed the 10‑15‑minute routine five days a week, achieving...
BeOne Medicines Recognized as "Outstanding Global Oncology Company of the Year" At HKCT Business Awards 2026
BeOne Medicines was named "Outstanding Global Oncology Company of the Year" at the 2026 HKCT Business Awards, recognizing its rapid R&D progress and manufacturing capabilities. The Swiss‑based firm now operates in more than 45 markets, employs over 1,200 oncology R&D...
Hong Kong Highlights Innovation and Greater Bay Area Collaboration at Hospital Authority Convention 2026
Hong Kong officials used the Hospital Authority Convention 2026 to unveil a suite of health‑innovation policies, including faster drug approvals, a new regulatory centre, and expanded AI use in hospitals. A Greater Bay Area Clinical Trial Collaboration Platform will allow...
Maintaining Trust in Medical AI: Monitoring and Managing Model Lifecycle
Artificial intelligence is becoming integral to health‑tech, powering diagnostics, decision support and patient management. However, models trained on historic data can lose accuracy as patient populations, clinical practices and data capture evolve. The article explains data drift (shifts in input...
Health Care Is a Right, Not a Profit Business
Health care should be a right not a for profit industry. The entire planet has free health care for its citizens. Only in America is a for profit industry. We don’t have to live like this.
ElITE 2026 – CHANGE MANAGEMENT CHAMPION – Amy Atwood
Amy Atwood, head of transformation and change management at Real Chemistry’s RC Resolve, brings three decades of experience guiding complex organizational change in healthcare and other sectors. Her people‑first methodology blends strategic discipline with behavioral insight, ensuring transformation initiatives are...
Medtronic Deploys AI‑Powered Stealth Axis Autopilot for Spine Surgery on West Coast
Medtronic introduced its AI‑enabled Stealth Axis Autopilot robotic platform in a spinal fusion at UC San Diego Health, where neurosurgeon Dr. Joseph Osorio used the system to place six screws across three vertebrae. The procedure demonstrates how machine‑learning models can...
FDA Says No Estrogen Patch Shortage Amid Widespread Pharmacy Reports
The FDA, led by Dr. Marty Makary, asserted Tuesday that estrogen patches are not officially in shortage, even as the American Society of Health‑System Pharmacists and clinicians report difficulty filling prescriptions. The disagreement underscores tension between regulatory data and on‑the‑ground...
CMS Proposes FY 2027 Medicare Hospital Payment Overhaul Emphasizing Quality and Equity
The Centers for Medicare & Medicaid Services released a proposed FY 2027 rule that revamps Medicare inpatient and long‑term care hospital payment systems. The plan adds new quality measures, expands equity safeguards, and adjusts payment formulas for rural hospitals, signaling...
Repatriation Flights Pose Minimal COVID Risk, WHO Confirms
WHO and each country have done good job of managing the disembarkation from the ship and repatriation. --> Risk of spread on the repatriation flight is low (masks, high ventilation/filtration on airplanes, private flights w/ no public, medical teams taking...
Make Healthcare Data Sharing as Standard as Banking
Imagine if your your school refused to share data with university admissions, or your bank refused to share your data with your lenders or your builder refused to share data with your roofer.... This is not normal. Make healthcare normal
Walking and Vigorous Exercise Cut Sleep Disruptions in Seniors with Mild Cognitive Impairment
Researchers monitoring seven seniors with mild cognitive impairment discovered that light activity such as walking and high‑intensity workouts reduced nighttime sleep disturbances, whereas moderate‑intensity cardio had no measurable effect. The findings could reshape exercise prescriptions for aging populations.
Both Health and Foster Systems Need Unified Individual View
There’s a fascinating parallel here between what leading #health systems are trying to accomplish in value-based care and what foster youth systems desperately need: a shared operational picture of the individual. https://t.co/om9O8rO3P8
Insurers Deny Care Yet Lack Required Malpractice Coverage
If insurance companies can deny care and call it "medically unnecessary", why aren't they required to have malpractice insurance doe when they get it wrong and someone gets sicker or tragically dies ?
FDA Approves Johnson & Johnson's Caplyta for Schizophrenia Relapse Prevention
The U.S. Food and Drug Administration approved Johnson & Johnson’s supplemental New Drug Application for Caplyta, extending its label to include relapse prevention in schizophrenia. The decision rests on a Phase III trial that showed a statistically significant delay in relapse...
Remote Nurse Robots Begin Deployment in U.S. Hospitals
Remotely Operated Nurse #Robots Are Entering U.S. Hospitals by @Khulood_Almani #Robotics #MedTech #HealthTech #Tech #Healthcare https://t.co/CKY0kbTmo4
Roche to Pay $750 Million Upfront for AI Diagnostics Pioneer PathAI
Swiss drugmaker Roche agreed to acquire Boston‑based PathAI for $750 million in cash, plus up to $300 million in milestone payments. The deal, slated to close in the second half of 2026, aims to embed AI into Roche’s global diagnostic platform and...
Cryo‑EM CRO Baiaode Secures ¥200 Million Series B to Scale Drug Discovery Platform
Baiaode, a China‑based cryo‑EM structural CRO, closed a ¥200 million ($28 million) Series B financing led by Kangjun Capital and Junlian Capital. The funds will boost its cryo‑EM infrastructure and fast‑track the three‑year “千靶万苗®” target‑and‑lead‑compound program, positioning the firm for deeper global...
AI-Assisted Breast Cancer Screening Study Shows Promise to Ease NHS Workload
Researchers analyzing data from more than 125,000 women demonstrated that an AI tool combined with a single human reader can match the diagnostic performance of two specialist readers in NHS breast cancer screening. The finding could cut radiology workload while...